• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血清补体因子 H 与狼疮肾炎患者的临床和病理活动相关。

Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis.

机构信息

Department of Medicine, Renal Division, Peking University First Hospital, Beijing, China.

出版信息

Rheumatology (Oxford). 2012 Dec;51(12):2269-77. doi: 10.1093/rheumatology/kes218. Epub 2012 Sep 6.

DOI:10.1093/rheumatology/kes218
PMID:22956549
Abstract

OBJECTIVE

The aim of this study was to investigate serum complement factor H (CFH) and its associations with clinical and pathological features in patients with LN.

METHODS

Serum CFH was detected in 241 LN patients, 38 active and 11 inactive patients with SLE without clinical evidence of renal involvement and 51 normal controls. Serum CFH autoantibodies and CFH Tyr402His were screened in the 241 LN patients. CFH deposition in kidneys was detected in some patients.

RESULTS

Serum CFH levels in patients with LN at active phase were significantly lower than in 38 SLE patients or in normal controls. No serum anti-CFH autoantibodies were detected in patients with LN, and there was no significant difference in CFH Tyr402His distribution between patients with LN and normal controls. Glomerular expression of CFH was stronger than in normal controls. Serum CFH levels were mildly negatively associated with SLEDAI scores (r = -0.204, P = 0.001) and positively associated with serum C3 (r = 0.367, P < 0.001) and haemoglobulin levels (r = 0.193, P = 0.003). Patients with LN class III, subclass IV-S and those with thrombotic microangiopathy had the lowest serum CFH.

CONCLUSION

Serum CFH levels were associated with disease activity of LN.

摘要

目的

本研究旨在探讨狼疮肾炎(LN)患者血清补体因子 H(CFH)及其与临床和病理特征的关系。

方法

检测了 241 例 LN 患者、38 例活动期和 11 例非活动期无肾外临床表现的系统性红斑狼疮(SLE)患者及 51 名正常对照者的血清 CFH。对 241 例 LN 患者进行了血清 CFH 自身抗体和 CFH Tyr402His 的筛查。对部分患者进行了肾脏 CFH 沉积的检测。

结果

活动期 LN 患者的血清 CFH 水平明显低于 38 例 SLE 患者和正常对照组。LN 患者未检测到血清抗 CFH 自身抗体,且 LN 患者与正常对照组 CFH Tyr402His 分布无显著差异。肾小球 CFH 表达强于正常对照组。血清 CFH 水平与 SLEDAI 评分呈轻度负相关(r=-0.204,P=0.001),与血清 C3(r=0.367,P<0.001)和血红蛋白水平(r=0.193,P=0.003)呈正相关。III 型、IV-S 型和血栓性微血管病患者的血清 CFH 水平最低。

结论

血清 CFH 水平与 LN 的疾病活动度有关。

相似文献

1
Serum complement factor H is associated with clinical and pathological activities of patients with lupus nephritis.血清补体因子 H 与狼疮肾炎患者的临床和病理活动相关。
Rheumatology (Oxford). 2012 Dec;51(12):2269-77. doi: 10.1093/rheumatology/kes218. Epub 2012 Sep 6.
2
Antinucleosome antibodies as a potential biomarker for the evaluation of renal pathological activity in patients with proliferative lupus nephritis.抗核小体抗体作为评估增生性狼疮肾炎患者肾脏病理活动的潜在生物标志物。
Lupus. 2011 Nov;20(13):1404-10. doi: 10.1177/0961203311417033. Epub 2011 Sep 26.
3
[The roles of complement 1q and anti-C1q autoantibodies in pathogenesis of lupus nephritis].[补体1q及抗C1q自身抗体在狼疮性肾炎发病机制中的作用]
Zhonghua Yi Xue Za Zhi. 2005 Apr 13;85(14):955-9.
4
Prospective assessment of C4d deposits on circulating cells and renal tissues in lupus nephritis: a pilot study.狼疮性肾炎中循环细胞和肾组织中 C4d 沉积的前瞻性评估:一项初步研究。
Lupus. 2012 Jan;21(1):13-26. doi: 10.1177/0961203311422093. Epub 2011 Sep 29.
5
Clinical relevance of glomerular IgM deposition in patients with lupus nephritis.狼疮肾炎患者肾小球 IgM 沉积的临床意义。
BMC Immunol. 2021 Dec 7;22(1):75. doi: 10.1186/s12865-021-00467-z.
6
Angiopoietin-2, endothelial dysfunction and renal involvement in patients with systemic lupus erythematosus.血管生成素-2、内皮功能障碍与系统性红斑狼疮患者的肾脏受累。
J Nephrol. 2012 Jul-Aug;25(4):541-50. doi: 10.5301/jn.5000030.
7
Serum albumin as a marker for disease activity in patients with systemic lupus erythematosus.血清白蛋白作为系统性红斑狼疮患者疾病活动的标志物。
J Rheumatol. 2010 Aug 1;37(8):1667-72. doi: 10.3899/jrheum.091028. Epub 2010 Jun 1.
8
Measurement of interleukin-1 receptor antagonist in patients with systemic lupus erythematosus could predict renal manifestation of the disease.系统性红斑狼疮患者白细胞介素-1 受体拮抗剂的测定可预测疾病的肾脏表现。
Hum Immunol. 2010 Sep;71(9):874-7. doi: 10.1016/j.humimm.2010.06.004. Epub 2010 Jun 9.
9
Anti-nucleosome antibodies as a disease marker in systemic lupus erythematosus and its correlation with disease activity and other autoantibodies.抗核小体抗体作为系统性红斑狼疮的疾病标志物及其与疾病活动和其他自身抗体的相关性。
Indian J Dermatol Venereol Leprol. 2010 Mar-Apr;76(2):145-9. doi: 10.4103/0378-6323.60558.
10
Anti-C1q antibodies and antiendothelial cell antibodies in systemic lupus erythematosus - relationship with disease activity and renal involvement.系统性红斑狼疮中的抗C1q抗体和抗内皮细胞抗体——与疾病活动度及肾脏受累的关系
Clin Rheumatol. 2003 Oct;22(4-5):271-8. doi: 10.1007/s10067-003-0724-3.

引用本文的文献

1
Systemic lupus erythematosus as the paradigm for understanding the complex immune relationships and therapeutic opportunities for targeting complement in autoimmune diseases.系统性红斑狼疮作为理解自身免疫性疾病中复杂免疫关系以及补体靶向治疗机会的范例。
Immunobiology. 2025 May;230(3):152915. doi: 10.1016/j.imbio.2025.152915. Epub 2025 May 20.
2
Complement System and the Kidney: Its Role in Renal Diseases, Kidney Transplantation and Renal Cell Carcinoma.补体系统与肾脏:在肾脏疾病、肾移植和肾细胞癌中的作用。
Int J Mol Sci. 2023 Nov 20;24(22):16515. doi: 10.3390/ijms242216515.
3
Efficacy and Safety of Belimumab in Lupus Nephritis Patients: A Real-World Observational Study in China.
贝利尤单抗在中国狼疮性肾炎患者中的疗效与安全性:一项真实世界观察性研究
Kidney Dis (Basel). 2023 Feb 14;9(3):218-228. doi: 10.1159/000529675. eCollection 2023 May.
4
Anti-complement factor H (CFH) autoantibodies could delay pristane-induced lupus nephritis.抗补体因子 H(CFH)自身抗体可延缓特发性脂膜炎相关性狼疮肾炎。
Immunol Res. 2023 Dec;71(6):849-859. doi: 10.1007/s12026-023-09396-y. Epub 2023 Jun 16.
5
Association of C-reactive protein and complement factor H gene polymorphisms with risk of lupus nephritis in Chinese population.中国人群中C反应蛋白和补体因子H基因多态性与狼疮性肾炎风险的关联
World J Clin Cases. 2023 May 6;11(13):2934-2944. doi: 10.12998/wjcc.v11.i13.2934.
6
Dysregulation of complement factor H in juvenile-onset systemic lupus erythematosus patients.青少年型系统性红斑狼疮患者补体因子H的失调
Arch Rheumatol. 2021 Dec 24;37(3):417-423. doi: 10.46497/ArchRheumatol.2022.9217. eCollection 2022 Sep.
7
Kidney diseases.肾脏疾病。
Immunol Rev. 2023 Jan;313(1):239-261. doi: 10.1111/imr.13167. Epub 2022 Nov 12.
8
Alternative pathway diagnostics.替代途径诊断。
Immunol Rev. 2023 Jan;313(1):225-238. doi: 10.1111/imr.13156. Epub 2022 Oct 28.
9
Low-molecular weight inhibitors of the alternative complement pathway.替代补体途径的低分子量抑制剂。
Immunol Rev. 2023 Jan;313(1):339-357. doi: 10.1111/imr.13143. Epub 2022 Oct 11.
10
Genetic analysis of CFH and MCP in Egyptian patients with immune-complex proliferative glomerulonephritis.CFH 和 MCP 在埃及免疫复合物增生性肾小球肾炎患者中的遗传分析。
Front Immunol. 2022 Sep 23;13:960068. doi: 10.3389/fimmu.2022.960068. eCollection 2022.